Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1994 Jun;219(6):688–692. doi: 10.1097/00000658-199406000-00012

Determination of endogenous cytokines in chronic wounds.

D M Cooper 1, E Z Yu 1, P Hennessey 1, F Ko 1, M C Robson 1
PMCID: PMC1243222  PMID: 8203978

Abstract

OBJECTIVE: This study objectively characterized the microenvironment of indolent, chronic wounds by developing a method by which minute quantities of cytokines could be extracted from chronic wounds and separately identified. SUMMARY BACKGROUND DATA: Recombinant DNA technology and the ability to clone compounds such as cytokines allow new management schemes for the treatment of acute and chronic wounds. Before treatment with an exogenous cytokine is started, it would be helpful to know the endogenous level of that cytokine in the wound. Although various methods of extracting cytokines from acute wounds have been reported, no techniques have existed to reliably measure endogenous levels of cytokines in chronic wounds. METHODS: Porous, inert hydrophilic dextranomer beads were tested for their ability to absorb or adsorb protein and cytokines in vitro with either albumin or albumin laced with various known amounts of cytokines, and then from chronic human pressure ulcers. The Bradford protein assay was used to determine protein levels. Enzyme-linked immunosorbent assay (ELISA) techniques were used to determine levels of platelet-derived growth factor (PDGF)-AB, basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), and transforming growth factor-Beta (TGF-beta) extracted by the beads. RESULTS: Between 88% and 98% of known amounts of albumin could be recovered. Similarly, more than 90% of the laced cytokines could be recovered. In 20 grade III/IV pressure ulcers, although protein concentrations were remarkably similar, endogenous levels of cytokine growth factors varied tremendously. Platelet-derived growth factor-AB ranged from 49 to 867 pg/mL; bFGF from 47 to 697 pg/mL; and EGF from nondetectable to 247.5 pg/mL. TGF-B was not detected in 17 of the 20 pressure ulcers. CONCLUSIONS: This new technique appears useful for measuring endogenous levels of cytokines. Levels of cytokines found in these chronic wounds are much lower than those reported from acute wounds. The marked variation found among the 20 wounds may help to explain the differences reported in recent wound healing trials with exogenous cytokines.

Full text

PDF
688

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett N. T., Schultz G. S. Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am J Surg. 1993 Jul;166(1):74–81. doi: 10.1016/s0002-9610(05)80589-6. [DOI] [PubMed] [Google Scholar]
  2. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  3. Breuing K., Eriksson E., Liu P., Miller D. R. Healing of partial thickness porcine skin wounds in a liquid environment. J Surg Res. 1992 Jan;52(1):50–58. doi: 10.1016/0022-4804(92)90278-8. [DOI] [PubMed] [Google Scholar]
  4. Brown G. L., Nanney L. B., Griffen J., Cramer A. B., Yancey J. M., Curtsinger L. J., 3rd, Holtzin L., Schultz G. S., Jurkiewicz M. J., Lynch J. B. Enhancement of wound healing by topical treatment with epidermal growth factor. N Engl J Med. 1989 Jul 13;321(2):76–79. doi: 10.1056/NEJM198907133210203. [DOI] [PubMed] [Google Scholar]
  5. Dvonch V. M., Murphey R. J., Matsuoka J., Grotendorst G. R. Changes in growth factor levels in human wound fluid. Surgery. 1992 Jul;112(1):18–23. [PubMed] [Google Scholar]
  6. Marikovsky M., Breuing K., Liu P. Y., Eriksson E., Higashiyama S., Farber P., Abraham J., Klagsbrun M. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc Natl Acad Sci U S A. 1993 May 1;90(9):3889–3893. doi: 10.1073/pnas.90.9.3889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Matsuoka J., Grotendorst G. R. Two peptides related to platelet-derived growth factor are present in human wound fluid. Proc Natl Acad Sci U S A. 1989 Jun;86(12):4416–4420. doi: 10.1073/pnas.86.12.4416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Picardo M., Schor S. L., Grey A. M., Howell A., Laidlaw I., Redford J., Schor A. M. Migration stimulating activity in serum of breast cancer patients. Lancet. 1991 Jan 19;337(8734):130–133. doi: 10.1016/0140-6736(91)90798-t. [DOI] [PubMed] [Google Scholar]
  9. Robson M. C., Phillips L. G., Lawrence W. T., Bishop J. B., Youngerman J. S., Hayward P. G., Broemeling L. D., Heggers J. P. The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores. Ann Surg. 1992 Oct;216(4):401–408. doi: 10.1097/00000658-199210000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Robson M. C., Phillips L. G., Thomason A., Altrock B. W., Pence P. C., Heggers J. P., Johnston A. F., McHugh T. P., Anthony M. S., Robson L. E. Recombinant human platelet-derived growth factor-BB for the treatment of chronic pressure ulcers. Ann Plast Surg. 1992 Sep;29(3):193–201. doi: 10.1097/00000637-199209000-00001. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES